• Users Online: 572
  • Print this page
  • Email this page
REVIEW ARTICLE
Year : 2021  |  Volume : 33  |  Issue : 3  |  Page : 203-211

Interleukin-10: A double-edged sword in breast cancer


1 Department of General Surgery, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation; Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan
2 Institute of Medical Sciences; Department of Biochemistry, School of Medicine, Tzu Chi University, Hualien, Taiwan
3 Department of Biochemistry, School of Medicine; Department of Life Sciences, College of Medicine, Tzu Chi University, Hualien, Taiwan
4 Department of Biochemistry, School of Medicine, Tzu Chi University, Hualien, Taiwan

Correspondence Address:
Hao-Jen Hsu
Department of Biochemistry, School of Medicine, Tzu Chi University, 701, Section 3, Zhongyang Road, Hualien
Taiwan
Shinn-Jong Jiang
Department of Biochemistry, School of Medicine, Tzu Chi University, 701, Section 3, Zhongyang Road, Hualien
Taiwan
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/tcmj.tcmj_162_20

Rights and Permissions

Breast cancer (BC) is a frequently diagnosed cancer among women worldwide. Currently, BC can be divided into different subgroups according to the presence of the following hormone receptors: estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2. Each of these subgroups has different treatment strategies. However, the presence of new metastatic lesions and patient deterioration suggest resistance to a given treatment. Various lines of evidence had shown that cytokines are one of the important mediators of tumor growth, invasion, metastasis, and treatment resistance. Interleukin-10 (IL-10) is an immunoregulatory cytokine, and acts as a poor prognostic marker in many cancers. The anti-inflammatory IL-10 blocks certain effects of inflammatory cytokines. It also antagonizes the co-stimulatory molecules on the antigen-presenting cells. Here, we review the current knowledge on the function and molecular mechanism of IL-10, and recent findings on how IL-10 contributes to the progression of BC.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1327    
    Printed34    
    Emailed0    
    PDF Downloaded171    
    Comments [Add]    

Recommend this journal